Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about FATE
Recent news which mentions FATE
< Previous
1
2
3
4
5
Next >
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022
June 03, 2022
Tickers
ADPT
AGLE
ALLO
AON
Tags
CORZ
NEO
VOYA
From
Benzinga
‘The capitulation model for biotech is a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy
May 20, 2022
Tickers
BMY
FATE
IBB
JNJ
Tags
OLMA
FATE
XBI
From
MarketWatch
Recap: Fate Therapeutics Q1 Earnings
May 04, 2022
Tickers
FATE
Tags
Market News
Earnings
BZI/Recaps
From
Benzinga
The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints
May 04, 2022
Tickers
AGTC
ALLO
ALNA
AMRN
Tags
ALNA
Health Care
APLS
From
Benzinga
These stocks soared during the pandemic, and then crashed. Ten are now expected to double in price.
May 02, 2022
Tickers
APPN
ARKK
BILI
BLDP
Tags
DNLI
Z
BILI
From
MarketWatch
What 4 Analyst Ratings Have To Say About Fate Therapeutics
March 04, 2022
Tickers
FATE
Tags
FATE
BZI/AAR
Benzinga
From
Benzinga
Fate Therapeutics: Q4 Earnings Insights
February 28, 2022
Tickers
FATE
Tags
FATE
Benzinga
Market News
From
Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
Tickers
AAON
ACAD
ACHC
AGM
Tags
STRL
PNTG
News
From
Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
Tickers
ACAD
ACLX
AMRN
AMRS
Tags
IBB
Market News
KOD
From
Benzinga
Fate Therapeutics's Earnings: A Preview
February 25, 2022
Tickers
FATE
Tags
Market News
BZI/EP
Earnings
From
Benzinga
Earnings Outlook For Fate Therapeutics
February 25, 2022
Tickers
FATE
Tags
Benzinga
FATE
Earnings
From
Benzinga
2 Natural-Killer Cell Therapy Oncology Companies Investors Should Watch
February 08, 2022
Tickers
BMY
FATE
IPSC
Tags
General
FATE
Biotech
From
Benzinga
Benzinga Asks: Which ARK Fund Would You Rather Buy And Hold For 5 Years?
January 14, 2022
Tickers
ARKF
ARKG
ARKK
ARKW
Tags
PATH
EXAS
ARKW
From
Benzinga
Here's How Much $100 Invested In Fate Therapeutics 5 Years Ago Would Be Worth Today
January 05, 2022
Tickers
FATE
Tags
Earnings
News
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
December 15, 2021
Tickers
ADGI
ALB
AMCR
APEN
Tags
CMA
BZI/Ratings
EW
From
Benzinga
10 Biggest Price Target Changes For Wednesday
December 15, 2021
Tickers
ADGI
BKNG
EW
FATE
Tags
SKYW
FATE
ADGI
From
Benzinga
The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
December 14, 2021
Tickers
APTO
ATRA
AZN
BLU
Tags
MOLN
Benzinga
NVS
From
Benzinga
Fate Therapeutics Showcases Interim Data From FT596 Cell Program In Lymphoma
December 14, 2021
Tickers
FATE
Tags
General
Health Care
lymphoma
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
December 07, 2021
Tickers
APD
APPS
ARVN
AZN
Tags
HQY
SFT
HYFM
From
Benzinga
Cathie Wood Likes Fate Therapeutics, Should You?
December 01, 2021
Tickers
FATE
TWST
Tags
Recent Press Releases
FATE
TWST
From
Motley Fool
3 Biotech Stocks That Can Double Your Money, According to Wall Street
November 25, 2021
Tickers
ADPT
AXSM
FATE
Tags
Market News
AXSM
FATE
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2021
November 09, 2021
Tickers
ADCT
ADMA
AQB
BPOP
Tags
INKT
VGR
AQB
From
Benzinga
Fate Therapeutics, inc (FATE) Q3 2021 Earnings Call Transcript
November 05, 2021
Tickers
FATE
Tags
Market News
FATE
Recent Press Releases
From
Motley Fool
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Tickers
AERI
ALGS
ALLO
ANIP
Tags
CLBS
NKTR
NVS
From
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Tickers
ADPT
AERI
AGIO
ALGS
Tags
SUPN
AGIO
FDA
From
Benzinga
3 Biotech Stocks to Watch Now
October 12, 2021
Tickers
ACAD
FATE
PIRS
Tags
Biotech
FATE
Market News
From
Benzinga
Recent Poor Results Have Made This Promising Cathie Wood Pick a Bargain
September 14, 2021
Tickers
ARKG
ARKK
FATE
Tags
ARKG
Market News
ARKK
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021
August 26, 2021
Tickers
AFCG
ALLK
APPH
AY
Tags
BZI/Ratings
ALLK
EVLV
From
Benzinga
58 Biggest Movers From Friday
August 23, 2021
Tickers
AMRS
ARAY
ARCE
ATER
Tags
NURO
Markets
NAKD
From
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 20, 2021
Tickers
ALLO
AXDX
ENDP
ENSC
Tags
ENDP
RGC
GOVX
From
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today